Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomoko Matsui

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Journal of the American Geriatrics Society|June 19, 2024
Pre-post-evaluation of a dementia-specific advance care planning toolkit for Japanese primary care cliniciansChristine E Kistler, Machiko Inoue, Tomoko Matsui, et al.
Environmental Health and Preventive Medicine|July 2, 2009
The relationship between long-term changes in plasma B-type natriuretic peptide levels and electrocardiographic findingsShinji Fukazawa, Koji Teruya, Takamoto Uemura, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 6, 2025
[Biological Differences between EGFR ex19del and ex21L858R-Preclinical Models Using an Engineered Pair of Isogenic NSCLC Cell Lines with CRISPR Engineering]Zhao Hai Lu, Tomoko Matsui, Audrey Au, et al.
Future Oncology (London, England)|September 25, 2025
RELAY: safety and efficacy of ramucirumab plus erlotinib in elderly Japanese patients with metastatic <i>EGFR</i>-mutated NSCLCKazumi Nishino, Takashi Seto, Makoto Nishio, et al.
JTO Clinical and Research Reports|April 4, 2022
RELAY+: Exploratory Study of Ramucirumab Plus Gefitinib in Untreated Patients With <i>EGFR</i>-Mutated Metastatic NSCLCMakoto Nishio, Kazuto Nishio, Martin Reck, et al.
JTO Clinical and Research Reports|November 24, 2025
RELAY+: Final Overall Survival With Ramucirumab Plus Gefitinib in Patients With Untreated <i>EGFR</i>-Mutated Metastatic NSCLCMakoto Nishio, Takashi Seto, Martin Reck, et al.
JTO Clinical and Research Reports|June 3, 2025
Final Survival Outcomes With Ramucirumab Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Untreated <i>EGFR</i>-Mutated Metastatic NSCLC: RELAY Japanese SubsetMakoto Nishio, Takashi Seto, Martin Reck, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Journal of the American Geriatrics Society|June 19, 2024
Pre-post-evaluation of a dementia-specific advance care planning toolkit for Japanese primary care cliniciansChristine E Kistler, Machiko Inoue, Tomoko Matsui, et al.
Environmental Health and Preventive Medicine|July 2, 2009
The relationship between long-term changes in plasma B-type natriuretic peptide levels and electrocardiographic findingsShinji Fukazawa, Koji Teruya, Takamoto Uemura, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 6, 2025
[Biological Differences between EGFR ex19del and ex21L858R-Preclinical Models Using an Engineered Pair of Isogenic NSCLC Cell Lines with CRISPR Engineering]Zhao Hai Lu, Tomoko Matsui, Audrey Au, et al.
Future Oncology (London, England)|September 25, 2025
RELAY: safety and efficacy of ramucirumab plus erlotinib in elderly Japanese patients with metastatic <i>EGFR</i>-mutated NSCLCKazumi Nishino, Takashi Seto, Makoto Nishio, et al.
JTO Clinical and Research Reports|April 4, 2022
RELAY+: Exploratory Study of Ramucirumab Plus Gefitinib in Untreated Patients With <i>EGFR</i>-Mutated Metastatic NSCLCMakoto Nishio, Kazuto Nishio, Martin Reck, et al.
JTO Clinical and Research Reports|November 24, 2025
RELAY+: Final Overall Survival With Ramucirumab Plus Gefitinib in Patients With Untreated <i>EGFR</i>-Mutated Metastatic NSCLCMakoto Nishio, Takashi Seto, Martin Reck, et al.
JTO Clinical and Research Reports|June 3, 2025
Final Survival Outcomes With Ramucirumab Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Untreated <i>EGFR</i>-Mutated Metastatic NSCLC: RELAY Japanese SubsetMakoto Nishio, Takashi Seto, Martin Reck, et al.
Pageof 5